EUIPO sides with Takeda in trademark appeal
28-11-2018
Japanese Takeda to acquire Shire for $62bn
08-05-2018
Takeda makes fourth offer to buy Shire
23-04-2018
william_potter / iStockphoto.com
Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Takeda Pharmaceuticals, Shire, acquisition, European Commission, regulatory approval, debt, over-the-counter, Federal Trade Commission
